Oncology & Cancer

Sutimlimab shows promise for hard-to-treat, rare blood disorder

In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no ...

Medical research

No bleeding required: Anemia detection via smartphone

Biomedical engineers have developed a smartphone app for the non-invasive detection of anemia. Instead of a blood test, the app uses photos of someone's fingernails taken on a smartphone to accurately measure how much hemoglobin ...

Diabetes

Basal insulin analogues similar for glucose lowering

(HealthDay)—Basal insulin analogues for type 2 diabetes mellitus (T2DM) do not substantially differ in their glucose-lowering effect, according to a review published online July 10 in the Annals of Internal Medicine.

Diabetes

Two regimens fail to stop declines in β-cell function

(HealthDay)—Neither glargine followed by metformin nor metformin alone halts the progressive deterioration of β-cell function in youth with impaired glucose tolerance (IGT) or recently-diagnosed type 2 diabetes, according ...

Diabetes

HbA1c targets should be personalized in type 2 diabetes

(HealthDay)—For non-pregnant adults with type 2 diabetes, hemoglobin A1c (HbA1c) targets should be personalized, according to a Clinical Guidelines Synopsis published in the June 19 issue of the Journal of the American ...

Diabetes

Food insecurity tied to poor glycemic control in diabetes

(HealthDay)—Limited food access owing to cost (food insecurity) is associated with increased hemoglobin A1c (HbA1C) among patients with diabetes, according to a study published online March 19 in Diabetes Care.

page 11 from 37